跳至主要内容
临床试验/NCT02015624
NCT02015624已完成不适用

EmploYEd Antithrombotic Therapies in Patients With Acute Coronary Syndromes HOspitalized in iTalian CCUs Registry

Heart Care Foundation203 个研究点 分布在 1 个国家目标入组 2,597 人开始时间: 2013年12月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
2,597
试验地点
203
主要终点
Antithrombotic drugs in patient undergoing percutaneous transluminal coronary angiography, coronary artery bypass graft or no coronary revascularization

研究概览

简要总结

This register will evaluate the use of different antithrombotic therapies, combinations of different drugs routinely used during any stage of hospital admission, with their timing, dosage and mode of administration, in patients with a diagnosis of Acute Coronary Syndrome in the Italian Coronary Care Unit during a study period of three weeks

研究设计

研究类型
Observational
观察模型
Other
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Antithrombotic drugs in patient undergoing percutaneous transluminal coronary angiography, coronary artery bypass graft or no coronary revascularization

时间窗: Participants will be followed for the duration of hospital stay, an expected average period of 7 days

次要结局

  • In-hospital ischemic and hemorrhagic events(Participants will be followed for the duration of hospital stay, an expected average period of 7 days)

研究者

发起方
Heart Care Foundation
申办方类型
Other
责任方
Sponsor

研究点 (203)

Loading locations...

相似试验